The Frankfurt Institute of Clinical Cancer Research (IKF)
Your Visions Translated Into Groundbreaking Research
We are IKF
We are a globally active Clinical Research Institution and Study Group, specializing in investigator-initiated and industry-academia collaborative clinical cancer research.
Founded by oncologists with a shared vision to make a global impact, our mission is to advance science-driven cancer research, conduct transformative trials, and provide answers to crucial clinical questions.
Facts And Figures About Our Activities Since 2018
Patients In Trials
Trial Sites
Academic Groups
Clinical Trials
Phase III Trials
Patients In Trial Annually
Our Research
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients.
Our Service
Through our Comprehensive Research Organization service (CRO), our work covers all areas of clinical cancer research at the highest level.
What Sets Us Apart
Our team of physicians, who have years of expertise and current knowledge in medical care, are specialized in the fields of hematology, oncology, surgical oncology, palliative medicine, supportive therapy, and human genetics. Our founders are oncologists, and this expertise is a hallmark of IKF.
With well-established networks of almost hundreds of medical institutions, the best experts in their respective fields for every disease type, and the largest academic study groups in Germany and Europe, IKF has a powerful network that sets us apart.
IKF provides well-established access to routine clinical oncology environments through long-term collaborations with university hospitals, other large hospitals, and private oncology practitioners.
Our interactive and comprehensive molecular profiling network, PLATON, provides a unique opportunity to screen a sufficient number of patients with distinct genetic alterations/mutations for biomarker-based clinical trials.
